How a premature ejaculation drug sparked a $150 million legal battle over trade secrets
From cnbc.com
Jeff Abraham tried to sell his sexual wellness start-up to household goods conglomerate Reckitt Benckiser for two years. But his dream ended one night in the fall of 2016 after a Pet Shop Boys concert in Las Vegas. Abraham's company Absorption Pharmaceuticals had what he considered a lucrative product called Promescent, which treated premature ejaculation, or PE. As he left the concert and walked out onto the Las Vegas Strip, his date noticed an advertisement on a massive electronic billboard across the street. "She goes, 'Hey, look, I think that's your product,'" he recalls. "I turned around and looked." The ad ...
(full story)